Metabolomic studies of breast cancer in murine models: A review
authors Araujo, R; Bispo, D; Helguero, LA; Gil, AM
nationality International
journal BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
author keywords Breast cancer; Murine models; Metabolomics; Metabonomics; Biomarkers; Diagnosis
keywords MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VIVO; ANIMAL-MODELS; MAMMARY-TUMOR; EX-VIVO; MASS-SPECTROMETRY; NMR-SPECTROSCOPY; LIPID-METABOLISM; MOUSE MODELS; DOXORUBICIN
abstract Background: Metabolomic strategies have been extensively used to search for biomarkers of disease, including cancer, in biological complex mixtures such as cells, tissues and biofluids. In breast cancer research, murine models are of great value and metabolomics has been increasingly applied to characterize tumor or organ tissues, or biofluids, for instance to follow-up metabolism during cancer progression or response to specific therapies. Scope of review: This review briefly introduces the different murine models used in breast cancer research and proceeds to present the metabolomic studies reported so far to describe the deviant metabolic behavior associated to breast cancer, in each type of model: xenografts (cell- or patient-derived), spontaneous (naturally-occurring or genetically engineered) and carcinogen-induced. The type of sample and strategies followed are identified, as well as the main findings from of study. Major conclusions: Metabolomics has gradually become relevant in characterizing murine models of breast cancer, using either Nuclear Magnetic Resonance (NMR) or Mass Spectromety (MS). Both tissue and biofluids are matrixes of interest in this context, although in some type of models, reports have focused primarily on the former. The aims of tissue studies have comprised the search for mechanistic knowledge of carcinogenesis, metastasis development and response/resistance to therapies. Biofluid metabolomics has mainly aimed at finding non-invasive biomarkers for early breast cancer detection or prognosis determination. General significance: Metabolomics provides exquisite detail on murine tumor and systemic metabolism of breast cancer. This knowledge paves the way for the discovery of new biomarkers, potentially translatable to in vivo non-invasive patient follow-up.
publisher ELSEVIER
issn 0925-4439
year published 2020
volume 1866
issue 5
digital object identifier (doi) 10.1016/j.bbadis.2020.165713
web of science category Biochemistry & Molecular Biology; Biophysics; Cell Biology
subject category Biochemistry & Molecular Biology; Biophysics; Cell Biology
unique article identifier WOS:000527949200022
  ciceco authors
  impact metrics
journal analysis (jcr 2019):
journal impact factor 4.352
5 year journal impact factor 5.386
category normalized journal impact factor percentile 76.772
dimensions (citation analysis):
altmetrics (social interaction):



 


Apoio

1suponsers_list_ciceco.jpg